We hear from pharmaceutical manufacturers from time to time that they're not prepared to come to Canada. This is something that they put out there.
They won't like me saying this, but there aren't a lot of very good examples out there. As for the few examples of products that haven't come to Canada, frankly, there are already alternatives on the market at low prices. The real reason they aren't coming, I believe, is that it's a not an opportunity for them to compete in Canada. They're not prepared to compete. I don't think there are a lot of examples.
If you pushed us to the New Zealand model, for example, that could be a real problem. There are some very important cancer drugs that aren't available in New Zealand unless you pay cash. There are limits.